Small Stocks, Big Money

RedChip Companies
  • 3.0 (2)
  • Business
  • Updated Semiweekly

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.

  1. 6d ago

    Bimergen Energy (NYSE American: BESS): Powering the Future of U.S. Battery Energy Storage

    Bimergen Energy Corporation (NYSE American: BESS) is a U.S. energy infrastructure developer, asset owner, and operator focused on utility-scale battery energy storage systems (BESS). The company has assembled a diversified pipeline of approximately 2.0 GW across major U.S. power markets, including ERCOT, PJM, WECC, and MISO. Bimergen is advancing its portfolio from development toward construction and commercialization through a capital-efficient strategy that combines institutional partnerships, project monetization, milestone payments, and retained ownership interests. Its portfolio includes the 100 MW / 400 MWh Redbird project near Houston and a growing portfolio of distributed battery storage assets. In Q2 2026, Bimergen reported $7.9 million in revenue, $3.9 million in Adjusted EBITDA, and $1.6 million in net income. The company also received $11 million in cash related to Q2 revenues and retained a 7.5% ownership interest in three monetized ERCOT projects totaling 480 MWh. Battery energy storage systems can help strengthen grid reliability by storing electricity during lower-cost periods and dispatching it when demand and prices rise. Bimergen is positioning its project pipeline to capitalize on growing demand for energy storage driven by renewable energy integration, electrification, and increasing power requirements across the U.S. Watch to learn more about Bimergen Energy’s strategy, 2.0 GW project pipeline, battery storage portfolio, and plans to participate in the continued buildout of U.S. energy infrastructure.NYSE American: BESSLearn more about Bimergen Energy (BESS): redchip.com/stocks/BESS#BESS #BimergenEnergy #BatteryStorage #EnergyStorage #CleanEnergy #EnergyInfrastructure #ERCOT #RenewableEnergy #GridStorage #NYSEAmerican #Investing #RedChip

  2. Sep 29

    Gold and Antinmony, Full Production by 2027 | Chris Gerteisen on Nova Minerals (NYSE-A: NVA)

    CEO Christopher Gertyson joins RedChip to detail how Nova Minerals (Nasdaq: NVA) is advancing a rare dual-commodity story at its flagship Estelle Project in Alaska — pairing near-term U.S. critical mineral production with one of the largest undeveloped gold resources in the world.Estelle is a district-scale project spanning 514 km² in the Tintina Gold Belt, hosting a 35 km mineralized corridor with more than 20 identified gold and antimony prospects. Nova is building a vertically integrated antimony business — mining and refining domestically in Alaska — to establish what Gertyson describes as the first fully domestic antimony supply chain in decades, with a secured refinery site at Port MacKenzie. Recent executive orders prioritizing Alaska's mineral resources and restricting antimony imports from foreign adversaries have sharpened the strategic case for Nova's "big three" critical minerals focus: antimony, tungsten, and gallium.The company's phase one antimony program is fully funded by a $43.4 million Department of War award under the Defense Production Act, targeting production of military-grade antimony trisulfide — used in small and medium caliber munitions primers — by 2026/27. On the gold side, Estelle hosts a 5.2 million ounce pit-constrained (S-K 1300) resource across the Correll and RPM deposits, including intercepts of 132 meters at 10.1 g/t gold (RPM-005) and 117 meters at 11.1 g/t gold (RPM-015). Nova holds an 85% ownership stake in the project and reports a market cap of roughly $481 million, with remaining cash reserves directed entirely toward advancing the gold asset alongside the fully-funded antimony work.Looking ahead, Gertyson outlined a feasibility study now underway, active season drilling at Corbal and RPM, and a goal of reaching a construction-ready gold project by 2028/2029. A successful phase one antimony ramp could unlock additional Department of War funding for phase two, scaling into refined products like antimony trioxide for broader U.S. industrial and defense markets. Gertyson frames the story simply: Nova is transitioning from explorer to producer, minimizing dilution while advancing what he calls one of the largest undeveloped gold projects in the world — critical minerals and gold, in America, for America.👉 Nova Minerals is a client of RedChip. To learn more about NVA and to read our full disclosure, visit: https://www.NVAinfo.com#NVA #NovaMinerals #Antimony #Gold #CriticalMinerals #Alaska #EstelleProject #DefenseStocks #MiningStocks #SmallCapStocks #MicroCapStocks #Nasdaq #InvestorEducation #StockInterviews

  3. Sep 22

    RedChip Highlights Alliance Entertainment Holding Corporation (NASDAQ: AENT) & BioVie (NASDAQ: BIVI)

    This week's episode of Small Stocks Big Money features exclusive interviews with senior executives from Alliance Entertainment Holding Corporation (NASDAQ: AENT) & BioVie (NASDAQ: BIVI)Explore the latest insights and updates in the world of small-cap stocks.Visit RedChip.com to learn more.

  4. Sep 15

    One Solution, Five Disease Pathways: CEO Pete O'Heeron on Fibrobiologic's (Nasdaq: FBLG) Fribroblast

    CEO Pete O'Heeron joins RedChip to explain why FibroBiologics (Nasdaq: FBLG) believes fibroblasts, not stem cells, represent the next major platform in regenerative medicine.FibroBiologics is a clinical-stage biotech built around a simple but underappreciated fact: fibroblasts, the cell type behind Dr. Shinya Yamanaka's Nobel Prize-winning discovery of induced pluripotent stem cells, appear to be more potent and more immune-modulating than the stem cells they helped create. They also outnumber stem cells roughly 5,000 to 1 in the human body. Rather than building around a single drug candidate, as many biotech companies do, FibroBiologics has used that abundance to construct a multi-program platform spanning wound care, orthopedics, autoimmune disease, oncology, and thymus regeneration — an approach O'Heeron says has produced clinical-stage success across every therapeutic pathway the company has pursued.The company's furthest-along program targets diabetic foot ulcers, where O'Heeron says fibroblasts do what they do best: heal wounds. It's a 12-week trial designed to validate in the clinic what has been shown in animal studies, healing time cut in half compared to a leading wound-care product from Smith & Nephew. That program sits alongside a broader pipeline spanning autoimmune disease, orthopedics, oncology, and thymus regeneration. The company says it has seen clinical success on every therapeutic pathway it has pursued so far. Its intellectual property position underpins that breadth: more than 250 patents issued and pending, covering therapeutic use of fibroblasts.👉 FibroBiologics is a client of RedChip. To learn more about FBLG and to read our full disclosure, visit: https://www.FBLGinfo.com#FBLG #FibroBiologics #Fibroblasts #CellTherapy #RegenerativeMedicine #StemCellAlternative #DiabeticFootUlcers #MultipleSclerosis #WoundCare #Biotech #SmallCapStocks #Nasdaq #InvestorEducation #StockInterviews

  5. Sep 8

    Autonomous Navigation in GPS-Denied Environments | CEO Ben Williams on Exyn Technologies (EXYN)

    Ben Williams, CEO and COO of Exyn Technologies (Nasdaq: EXYN), explains how the company's ExynAI platform solves one of robotics' hardest problems: navigating and mapping in places where GPS simply doesn't work.Exyn is an autonomous robotics and geospatial intelligence company built on its proprietary Level 4B autonomy platform, which enables drones and robots to navigate, map, and collect survey-grade data without GPS, communications links, prior maps, or external infrastructure — what the company calls "infrastructureless autonomy." That capability is critical underground, below tree canopy, indoors, and in contested defense environments, positioning Exyn across a combined addressable market exceeding $70 billion in mining, infrastructure, construction, geospatial, and defense.The technology has been commercially proven for six years, with external users completing over 1,000 autonomous missions monthly. The company is now transitioning toward a scalable software model through its ExynAI SDK, enabling OEM and third-party licensing, while its Range subsidiary pursues defense and government contracts. Ben also discusses Exyn's green UAS certification process for Nexus — a step toward larger U.S. government and defense procurement — and how the company's self-contained autonomy lets it expand into new industries and environments without additional infrastructure or training.👉 Exyn Technologies is a client of RedChip. To learn more about EXYN and to read our full disclosure, visit: EXYNinfo.com#EXYN #ExynTechnologies #AutonomousRobotics #DroneStocks #DefenseTech #ISR #GeospatialIntelligence #Nasdaq

  6. Sep 1

    8 Products, One Ore Body, $560/Ton Margin: CEO Mark Smith on NioCorp's Updated Feasibility Study

    CEO Mark Smith joins RedChip to break down NioCorp's (Nasdaq: NB) newly updated Elk Creek feasibility study and the company's expanding role in U.S. critical minerals supply.NioCorp Developments is advancing the Elk Creek Critical Minerals Project in Nebraska, a domestic source of niobium, scandium, titanium, and magnetic rare earth elements the U.S. currently imports at rates Smith details in the interview. As Smith explains, the updated feasibility study reflects "a tremendous amount of work" on metallurgy, with the project now positioned to produce eight distinct products from a single ore body — what he calls "a risk mitigation device for a mining company" rarely seen in the industry.The additional product streams translate directly to economics: Smith states the margin on the ore body is about $560 per ton of ore, against a mine plan of roughly one million tons of ore per year. On the scandium side, Smith discusses NioCorp's work with the Department of War, including the $10 million grant received in August 2025, and a newly announced non-binding memorandum of understanding with Lockheed Martin for the potential purchase of "up to 15 tons per year of scandium" from the Elk Creek operation. Smith also references the company's ongoing weekly discussions with the U.S. Export-Import Bank as it works toward financing to reach construction.Smith closes by describing scandium as one of the more overlooked pieces of NioCorp's portfolio today, but one he expects to become "one of the flashier pieces of our project" as the defense and aerospace applications gain traction. NioCorp holds locked-in offtake agreements covering 75% of planned niobium output with Thyssenkrupp and Traxys North America, alongside the largest scandium sales deal on record with Traxys.👉 NioCorp Developments (NB) is a client of RedChip. To learn more about NB and to read our full disclosure, visit: redchip.com/stocks/NB#NB #NioCorp #CriticalMinerals #RareEarths #Scandium #Niobium #Nasdaq #SmallCapStocks #MicroCapStocks #DefenseStocks #NationalSecurity #MiningStocks #InvestorEducation #StockInterviews

  7. Aug 25

    Tokenizing Wall Street: David Wachsman on Hawkeye Digital (OTC: HWKE)

    Visit RedChip.com to learn David Wachsman, President of Hawkeye Digital, Inc. (OTC: HWKE), joins RedChip to break down a new platform built to bridge Wall Street and the digital asset industry.Hawkeye is building an integrated merchant banking and private equity platform focused on the institutionalization of digital assets. Rather than depending on token price swings, the Company earns advisory fees and minority stakes through merchant banking engagements, while its private equity arm acquires majority stakes in mature, cash-flow generating crypto businesses. Wachsman, who founded blockchain communications firm Wachsman in 2015, brings over a decade of advisory relationships across the industry's leading players to source proprietary deal flow that traditional PE firms and investment banks can't easily replicate.In the interview, Wachsman outlines Hawkeye's two business lines, the type of acquisition targets the Company looks for (established, cash-generating businesses with product-market fit rather than early-stage startups), and the opportunity he sees in the tokenization of real-world assets as Wall Street shifts to blockchain rails. He also discusses Hawkeye's leadership team, pairing his deal-sourcing network with decades of capital markets experience from co-founder Marty Sumichrast and the board.Hawkeye is executing a path toward a national exchange uplisting, backed by ThinkEquity as financial advisor, aiming to expand investor awareness, trading liquidity, and institutional ownership as the Company builds its portfolio.👉 Hawkeye Digital is a client of RedChip. To learn more about HWKE and to read our full disclosure, visit: redchip.com/stocks/HWKE#HWKE #HawkeyeDigital #DigitalAssets #Crypto #Blockchain #MerchantBanking #PrivateEquity #Tokenization #SmallCapStocks #MicroCapStocks #OTCStocks #InvestorEducation #StockInterviews #CryptoStocksmore.

  8. Aug 11

    RedChip Highlights Virax Biolabs Group (NASDAQ: VRAX) & TransCode Therapeutics (NASDAQ: RNAZ)

    This week's episode of Small Stocks Big Money features exclusive interviews with senior executives from Virax Biolabs Group (NASDAQ: VRAX) & TransCode Therapeutics (NASDAQ: RNAZ)Explore the latest insights and updates in the world of small-cap stocks.Visit RedChip.com to learn more.

See All (158)

Ratings & Reviews

3
out of 5
2 Ratings

About

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.

Information

  • Creator
    RedChip Companies
  • Years Active
    2023 - 2026
  • Episodes
    158
  • Rating
    Clean
  • Copyright
    © RedChip Companies
  • Show Website
    Small Stocks, Big Money

You Might Also Like